MedTrace Logo

Hydroxyapetite Nanoparticles, Tricalcium Phosphate Nanoparticles, and PRF for Treatment of Gingival Recession

NCT06016894 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-08-30

No results posted yet for this study

Summary

The aim of the present study was to compare between nanocrystalline hydroxyapatite and tricalcium phosphate carried on PRP membrane in treatment of Miller's class 1 gingival recession in human.

Conditions

  • Periodontitis

Interventions

PROCEDURE

coronally advanced flap

coronally advanced flap operation

OTHER

Nanocrystalline hydroxyapatite loaded in PRF

Nanocrystalline hydroxyapatite loaded in PRF

OTHER

Nanocrystalline tricalcium phosphate loaded in PRF

Nanocrystalline tricalcium phosphate (NcTCP) loaded in PRF

Sponsors & Collaborators

  • October 6 University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-09-01
Primary Completion
2022-09-20
Completion
2023-04-22

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06016894 on ClinicalTrials.gov